Medical Articles 11/15

Posted by rob on November 15, 2008 under Uncategorized | Be the First to Comment

c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.

Additional acquisition of t(1;21)(p32;q22) in a patient relapsing with acute myelogenous leukemia with NUP98-HOXA9.

Smenospongine, a sesquiterpene aminoquinone from a marine sponge, induces g1 arrest or apoptosis in different leukemia cells.

BCR-ABL-transformed GMP as myeloid leukemic stem cells.

Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population.

Medical Articles 11/13

Posted by rob on November 13, 2008 under Uncategorized | Be the First to Comment

Cytotoxic prenylated xanthones from Calophyllum inophyllum.

Paradoxical Clinical Effects of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors for Acute Myelogenous Leukemia.

Disseminated tuberculosis following second unrelated cord blood transplantation for acute myelogenous leukemia.

Myelodysplastic syndromes: More prevalent than we know.

Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance.

The double deceit generated by an insertion mechanism in chronic myeloid leukemia with t(9;9;22).

Hematopoietic cell kinase (Hck) isoforms and phagocyte duties – from signaling and actin reorganization to migration and phagocytosis.

Medical Articles 11/9

Posted by rob on November 9, 2008 under Uncategorized | Be the First to Comment

Phase III Multi-Institutional Trial of Adjuvant Chemotherapy with Paclitaxel, Estramustine, and Oral Etoposide Combined with Long-Term Androgen Suppression Therapy and Radiotherapy Versus Long-Term Androgen Suppression Plus Radiotherapy Alone For High-Risk Prostate Cancer: Preliminary Toxicity Analysis of RTOG 99-02.

Oncophage: step to the future for vaccine therapy in melanoma.

Outcome and Medical Costs of Patients with Invasive Aspergillosis and Acute Myelogenous Leukemia-Myelodysplastic Syndrome Treated with Intensive Chemotherapy: An Observational Study.

A population study of imatinib in chronic myeloid leukaemia demonstrates lower efficacy than in clinical trials.

Medical Articles 11/8

Posted by rob on November 8, 2008 under Uncategorized | Be the First to Comment

Transient trisomy 8 abnormality in Philadelphia-negative cells during imatinib mesylate treatment of chronic myelogenous leukemia.

home top